ArticleIn vivo (Athens, Greece)

New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation.

Vera Dalla Via et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.